Cas:78813-13-5 4-nitrophenol-ul-14c manufacturer & supplier

We serve Chemical Name:4-nitrophenol-ul-14c CAS:78813-13-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-nitrophenol-ul-14c

Chemical Name:4-nitrophenol-ul-14c
CAS.NO:78813-13-5
Synonyms:4-nitrophenol-ul-14c
Molecular Formula:C6H5NO3
Molecular Weight:151.06400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:215.8ºC at 760 mmHg
Density:1.395 g/cm3
Index of Refraction:
PSA:66.05000
Exact Mass:151.04600
LogP:1.82360

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2910 7
Packing Group:


Contact us for information like 4-nitrophenol-ul-14c chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-nitrophenol-ul-14c physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-nitrophenol-ul-14c Use and application,4-nitrophenol-ul-14c technical grade,usp/ep/jp grade.


Related News: Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. 4-nitrophenol-ul-14c manufacturer In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. 4-nitrophenol-ul-14c supplier More than 2,000 new cases were also recorded in the country in the past 24 hours, raising the worldwide total to nearly 14,380, according to Chinese and World Health Organization data. The vast majority of the cases are inside China; about 100 cases have been confirmed in at least 23 other countries. 4-nitrophenol-ul-14c vendor In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of ��predictable�� clinical value for life-threatening diseases for which effective treatment is not immediately available. 4-nitrophenol-ul-14c factory Javier Valero-Elizondo, M.D., M.P.H., from the Houston Methodist DeBakey Heart and Vascular Center in Texas, and colleagues compared FT for individuals with ASCVD only, cancer only, both ASCVD and cancer, and neither ASCVD nor cancer using data from the National Health Interview Survey.